Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2030: COVID-19 Impact And Recovery

Veterinary Pharmaceuticals Global Market Opportunities And Strategies To 2030:COVID-19 Impact and Recovery from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global veterinary pharmaceuticals market.

Reasons to Purchase:
Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis


Description:
Where is the largest and fastest growing market for the veterinary pharmaceuticals market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The global veterinary pharmaceuticals market opportunities and strategies to 2030 report from the Business Research Company answers all these questions and many more.
The report covers the following chapters:

Executive Summary – The executive summary section of the report gives a brief overview and summary of the report.
Report Structure – This section gives the structure of the report and the information covered in the various sections.
Introduction – The introduction section gives the segmentation of the veterinary pharmaceuticals market by geography, by type of product, by animal type, by route of administration and by end use channel.
Market Characteristics – The market characteristics section of the report defines and explains the veterinary pharmaceuticals market. This chapter includes different products covered in the report and basic definitions.
Supply Chain – The supply chain section of the report defines and explains the key players in the veterinary pharmaceuticals industry supply chain.
Product Analysis – The product analysis section of the report describes the leading products along with key features and differentiators for those products/services.
Customer Information – This chapters covers recent customer and service providers’ trends/preferences in the global veterinary pharmaceuticals market.
Trends And Strategies – This chapter describes the major trends shaping the global veterinary pharmaceuticals market. This section highlights likely future developments in the market and suggests approaches companies can take to exploit these opportunities.
Regulatory Landscape– The section briefs on the regulatory landscape of veterinary pharmaceuticals.
Impact Of COVID-19 – The section briefs on the impact of COVID-19 on the veterinary pharmaceuticals market.
Global Market Size And Growth – This section contains the global historic (2015-2020) and forecast (2020-2025, 2030) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast period.
Segmentation – This section contains the market values (2015-2025, 2030F) and analysis for different segments in the market.
Global Macro Comparison – The global veterinary pharmaceuticals market comparison with macro-economic factors gives the veterinary pharmaceuticals market size, percentage of GDP, and average veterinary pharmaceuticals market expenditure.
Regional Analysis – This section contains the historic (2015-2020) and forecast (2020-2025, 2030F) market value and growth, and market share comparison by region.
Regional Market Size and Growth – This section contains the region’s market size (2020), historic (2015-2020) and forecast (2020-2025, 2030F) market value, and growth and market share comparison of major countries within the region. This report includes information on all the regions (Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa), and five countries (China, India, Japan, the USA and the UK).
Competitive Landscape – This section covers details on the competitive landscape of the global veterinary pharmaceuticals market, estimated market shares and company profiles of the leading players.
Key Mergers And Acquisitions – This chapter gives the information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
Market Background – This section describes the animal medicine market of which the veterinary pharmaceuticals market is a segment. This chapter includes the animal medicine market 2015-2025, 2030F values, and regional analyses for the animal medicine market.
Opportunities And Strategies – This section gives information on growth opportunities across countries, segments and strategies to be followed in those markets. It gives an understanding of where there is significant business to be gained by competitors in the next five years.
Conclusions And Recommendations – This section includes conclusions and recommendations based on findings of the research.
Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered: 1) By Type Of Pharamaceutical: Veterinary Parasiticides; Veterinary Vaccines; Veterinary Antibiotics; Other Veterinary Pharmaceuticals
2) By Animal Type: Livestock; Companion Animal
3) By Route Of Administration: Oral; Others
4) By End Use Channel: Veterinary Hospitals; Pharmacies and Drug stores; Veterinary Clinics
5) By Type Of Antibiotic: Tetracyclines; Penicillin; Macrolides; Sulphanomides; Aminoglycosides; Others
6) By Type Of Vaccine: Live Attenuated Vaccines; Inactivated Vaccines; Recombinant Vaccines; Others

Companies Mentioned: Zoetis Inc.; Boehringer Ingelheim GmbH; Merck & Co., Inc.; Elanco Animal Health Incorporated; Ceva Santé Animale

Countries: China; India; Japan; Australia; Indonesia; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.


1. Veterinary Pharmaceuticals Market Executive Summary
2. Table of Contents
3. List of Figures
4. List of Tables
5. Report Structure
6. Introduction
6.1. Segmentation By Geography
6.2. Segmentation By Type Of Pharmaceuticals
6.3. Segmentation By Animal Type
6.4. Segmentation By Route Of Administration
6.5. Segmentation By End Use Channel
6.6. Segmentation By Type Of Vaccines
6.7. Segmentation By Type Of Antibiotics
7. Veterinary Pharmaceuticals Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Type Of Product
7.2.1. Veterinary Vaccines
7.2.2. Veterinary Antibiotics
7.2.3. Veterinary Parasiticides
7.2.4. Other Veterinary Pharmaceuticals
7.3. Market Segmentation By End Use Channel
7.3.1. Veterinary Hospitals
7.3.2. Veterinary Clinics
7.3.3. Pharmacies And Drug Stores
7.4. Market Segmentation By Route Of Administration
7.4.1. Oral
7.4.2. Others
7.5. Market Segmentation By Type Of Animal
7.5.1. Livestock
7.5.2. Companion Animals
7.6. Market Segmentation By Type Of Vaccine
7.6.1. Inactivated Vaccines
7.6.2. Attenuated Vaccines
7.6.3. Recombinant Vaccines
7.6.4. Others
7.7. Market Segmentation By Type Of Antibiotics
7.7.1. Tetracyclines
7.7.2. Penicillin
7.7.3. Sulphonamides
7.7.4. Macrolides
7.7.5. Aminoglycosides
7.7.6. Others
8. Veterinary Pharmaceuticals Market, Supply Chain Analysis
8.1. Raw Material Suppliers
8.2. Contract Research Organization (CRO)
8.3. Veterinary Pharmaceutical Manufacturer
8.3.1. Drug Discovery
8.3.2. Preclinical And Clinical Trials
8.3.3. Patents Upon Discovery And Approval
8.3.4. Drug Manufacturing
8.4. Contract Manufacturing Organization (CMO)
8.5. Wholesalers/Distributors
8.6. Retailers (Pharmacies And Veterinary Shops) And Veterinary Clinics
8.7. Veterinarians
8.8. End-Users
9. Veterinary Pharmaceuticals Market, Product/Service Analysis –Product/Service Examples
10. Veterinary Pharmaceuticals Market Customer Information
10.1. Delay In Veterinary Care Due To COVID-19
10.2. Impact Of COVID-19 On Veterinary Hospitals
10.3. Veterinary Telemedicine For Chronic Disease Management
10.4. Impact Of Parasites On Pets Health
10.5. Decrease In Veterinary Clinical Activities
10.6. Millennials Would Put Pet's Health Before Their Own
10.7. Dog And Cat Owners Alike Are Concerned About The Cost Of Medical Treatments For Their Pets
10.8. Lack Of Awareness Among Food Animal Producers About The Proper Use Of Antibiotics
10.9. Opioids Shortages Compel Veterinarians To Use Less Effective Drugs As Therapeutic Choices
10.10. US Veterinarians Are Reluctant To Discuss The Therapeutic Use Of Marijuana In Dogs
10.11. Pet Ownership In The USA Has Tripled Over The Past Few Years
10.12. Pet Insurance Penetration In The USA Is Very Low
10.13. Cat And Dog Medications Are Still Sold Mainly In Veterinary Clinics
10.14. Pet Obesity Remains A Big Issue
10.15. The More Pet Owners Learn About Scientific Research On The Benefits Of The Human-Animal Bond, The More Likely They Are To Take Actions To Improve Pet Health.
11. Veterinary Pharmaceuticals Market Trends And Strategies
11.1. Strategic Collaborations And Partnerships To Drive Innovations
11.2. Development Of Chewable Tablets
11.3. Production Of Generic Drugs For Animal Care
11.4. Application Of Nanotechnology In Veterinary Medicines To Tackle Antibiotic Resistance
11.5. Oral Drug Solutions For The Treatment Of Feline Hypertension
11.6. Use of Subunit And Virus-Like Particle (VLP)-Based Vaccines
11.7. Use Of Immunotherapy
11.8. Super-Combo Parasiticides
11.9. Development Of Vaccines
11.10. New Treatments For Arthritis
11.11. Use Of Next Generation Sequencing (NGS)
12. Global Veterinary Pharmaceuticals Market Regulatory Landscape
12.1. Need For Separate Regulation For The Veterinary Pharmaceuticals Industry
12.2. Current Regulatory Scenario
12.2.1. USA
12.2.2. Europe
12.2.3. India
12.2.4. Brazil
12.2.5. Australia and New Zealand
12.2.6. Africa
12.3. Regional Disparities In Regulations
12.3.1. Lack Of Regulatory Guidance
12.3.2. Variations In Veterinary Pharmaceuticals Development Processes
12.3.3. Variations In Safety Considerations For Veterinary Pharmaceuticals
12.3.4. Differences In Registration Procedures
12.4. Global Regulation Harmonization Initiatives
12.5. Recent Updates On Veterinary Pharmaceutical Regulations
13. COVID-19 Impact On The Veterinary Pharmaceuticals Market
13.1. Supply Side Factors
13.1.1. Impact On Leading Global Veterinary Pharmaceuticals Companies
13.1.2. Decline In The Launch Of New Products
13.1.3. Safety Measures Being Followed By Veterinary Pharmaceuticals Manufacturers
13.1.4. Revocation Of Events, Conferences And Expos
13.2. Demand Side Factors
13.2.1. Stockpiling Of Veterinary Pharmaceuticals (Panic Purchasing)
13.2.2. Online Purchasing Of Veterinary Pharmaceuticals
13.2.3. Increase In Pet Ownership And Adoptions
13.2.4. Only Emergency Services Being Offered By Veterinarians
13.3. Regulatory Interventions
13.4. Future Outlook
14. Global Veterinary Pharmaceuticals Market Size And Growth
14.1. Market Size
14.2. Historic Market Growth, 2015 – 2020, Value ($ Million)
14.2.1. Drivers Of The Market 2015 – 2020
14.2.2. Emerging Markets Growth
14.2.3. Increased Pet Spending
14.2.4. Increased Disease Prevalence
14.2.5. Restraints On The Market 2015 – 2020
14.2.6. Shortages Of Veterinarians
14.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
14.3.1. Drivers Of The Market 2020 – 2025
14.3.2. Increasing Penetration Of Pet Insurance
14.3.3. Restraints On The Market 2020 – 2025
15. Global Veterinary Pharmaceuticals Market Segmentation
15.1. Global Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15.1.1. Veterinary Parasiticides
15.1.2. Veterinary Vaccines
15.1.3. Others-Veterinary Pharmaceuticals
15.1.4. Veterinary Antibiotics
15.2. Global Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15.2.1. Livestock
15.2.2. Companion Animal
15.3. Global Veterinary Pharmaceuticals Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15.3.1. Oral
15.4. Global Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
15.4.1. Veterinary Hospitals
15.4.2. Pharmacies And Drug stores
15.4.3. Veterinary Clinics
16. Global Veterinary Pharmaceuticals Market Sub-Segmentation
16.1. Global Veterinary Vaccines Market, Segmentation By Type Of Vaccine, Historic And Forecast, 2015-2020, 2025F, 2030F, Value ($ Million)
16.1.1. Live Attenuated Vaccines
16.1.2. Inactivated Vaccines
16.1.3. Recombinant Vaccines
16.1.4. Others
16.2. Global Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015-2020, 2025F, 2030F, Value ($ Million)
16.2.1. Others
16.2.2. Tetracyclines
16.2.3. Penicillins
16.2.4. Macrolodes
16.2.5. Sulphonamides
16.2.6. Aminoglycosides
17. Veterinary Pharmaceuticals Market, Regional And Country Analysis
17.1. Global Veterinary Pharmaceuticals Market, By Region, Historic and Forecast, 2015-2020, 2025F, 2030F, Value ($ Million)
17.2. Global Veterinary Pharmaceuticals Market, By Country, Historic and Forecast, 2015-2020, 2025F, 2030F, Value ($ Million)
18. Asia-Pacific Veterinary Pharmaceuticals Market
18.1. Asia-Pacific Veterinary Pharmaceuticals Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. COVID-19 Impact
18.1.4. Background Information
18.1.5. Government Initiatives
18.1.6. Regulations
18.1.7. Regulatory Bodies
18.1.8. Major Associations
18.1.9. Tax Levied
18.1.10. Corporate Tax Structure
18.1.11. Investments
18.1.12. Major Companies
18.2. Asia-Pacific Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
18.3. Asia-Pacific Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
18.4. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.5. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.6. Asia-Pacific Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.7. Asia-Pacific Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.8. Asia-Pacific Veterinary Pharmaceuticals Market: Country Analysis
18.9. Australia Veterinary Pharmaceuticals Market
18.10. Australia Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
18.11. Australia Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
18.12. Australia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.13. Australia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.14. Australia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.15. Australia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.16. China Veterinary Pharmaceuticals Market
18.17. China Veterinary Pharmaceuticals Market Overview
18.17.1. Country Information
18.17.2. Market Information
18.17.3. COVID-19 Impact
18.17.4. Background Information
18.17.5. Government Initiatives
18.17.6. Regulations
18.17.7. Regulatory Bodies
18.17.8. Corporate Tax Structure
18.17.9. Associations
18.17.10. Tax Levied
18.17.11. Investments
18.17.12. Major Companies
18.18. China Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
18.19. China Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
18.20. China Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.21. China Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.22. China Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.23. China Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.24. Indonesia Veterinary Pharmaceuticals Market
18.25. Indonesia Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
18.26. Indonesia Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
18.27. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.28. Indonesia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.29. Indonesia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.30. Indonesia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.31. India Veterinary Pharmaceuticals Market
18.32. India Veterinary Pharmaceuticals Market Overview
18.32.1. Country Information
18.32.2. Market Information
18.32.3. COVID-19 Impact
18.32.4. Background Information
18.32.5. Government Initiatives
18.32.6. Regulations
18.32.7. Regulatory Bodies
18.32.8. Major Associations
18.32.9. Tax Levied
18.32.10. Corporate Tax Structure
18.32.11. Investments
18.32.12. Major Companies
18.33. India Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
18.34. India Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
18.35. India Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.36. India Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.37. India Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.38. India Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.39. Japan Veterinary Pharmaceuticals Market
18.40. Japan Veterinary Pharmaceuticals Market Overview
18.40.1. Country Information
18.40.2. Market Information
18.40.3. COVID-19 Impact
18.40.4. Background Information
18.40.5. Regulations
18.40.6. Regulatory Bodies
18.40.7. Major Associations
18.40.8. Tax Levied
18.40.9. Corporate Tax Structure
18.40.10. Investments
18.40.11. Major Companies
18.41. Japan Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
18.42. Japan Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
18.43. Japan Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.44. Japan Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.45. Japan Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.46. Japan Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.47. South Korea Veterinary Pharmaceuticals Market
18.48. South Korea Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
18.49. South Korea Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
18.50. South Korea Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.51. South Korea Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.52. South Korea Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
18.53. South Korea Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19. Western Europe Veterinary Pharmaceuticals Market
19.1. Western Europe Veterinary Pharmaceuticals Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. COVID-19 Impact
19.1.4. Background Information
19.1.5. Government Initiatives
19.1.6. Regulations
19.1.7. Regulatory Bodies
19.1.8. Major Associations
19.1.9. Corporate Tax Structure
19.1.10. Investments
19.1.11. Major Companies
19.2. Western Europe Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.3. Western Europe Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.4. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.5. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.6. Western Europe Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.7. Western Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.8. Western Europe Veterinary Pharmaceuticals Market: Country Analysis
19.9. France Veterinary Pharmaceuticals Market
19.10. France Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.11. France Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.12. France Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.13. France Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.14. France Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.15. France Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.16. Germany Veterinary Pharmaceuticals Market
19.17. Germany Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.18. Germany Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.19. Germany Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.20. Germany Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.21. Germany Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.22. Germany Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.23. UK Veterinary Pharmaceuticals Market
19.24. UK Veterinary Pharmaceuticals Market Overview
19.24.1. Country Information
19.24.2. Market Information
19.24.3. COVID-19 Impact
19.24.4. Background Information
19.24.5. Government Initiatives
19.24.6. Regulations
19.24.7. Regulatory Bodies
19.24.8. Major Associations
19.24.9. Corporate Tax Structure
19.24.10. Investments
19.24.11. Major Companies
19.25. UK Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
19.26. UK Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
19.27. UK Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.28. UK Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.29. UK Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
19.30. UK Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
20. Eastern Europe Veterinary Pharmaceuticals Market
20.1. Eastern Europe Veterinary Pharmaceuticals Market Overview
20.1.1. Region Information
20.1.2. Market Information
20.1.3. COVID-19 Impact
20.1.4. Background Information
20.1.5. Government Initiatives
20.1.6. Regulations
20.1.7. Regulatory Bodies
20.1.8. Major Associations
20.1.9. Tax Levied
20.1.10. Corporate Tax Structure
20.1.11. Investments
20.1.12. Major Companies
20.2. Eastern Europe Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
20.3. Eastern Europe Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20.4. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
20.5. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
20.6. Eastern Europe Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
20.7. Eastern Europe Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
20.8. Russia Veterinary Pharmaceuticals Market
20.9. Russia Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
20.10. Russia Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
20.11. Russia Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
20.12. Russia Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
20.13. Russia Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
20.14. Russia Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
21. North America Veterinary Pharmaceuticals Market
21.1. North America Veterinary Pharmaceuticals Market Overview
21.1.1. Region Information
21.1.2. Market Information
21.1.3. COVID-19 Impact
21.1.4. Background Information
21.1.5. Government Initiatives
21.1.6. Regulations
21.1.7. Regulatory Bodies
21.1.8. Major Associations
21.1.9. Tax Levied
21.1.10. Corporate Tax Structure
21.1.11. Major Investments
21.1.12. Major Companies
21.2. North America Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
21.3. North America Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
21.4. North America Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
21.5. North America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
21.6. North America Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
21.7. North America Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
21.8. USA Veterinary Pharmaceuticals Market
21.9. USA Veterinary Pharmaceuticals Market Overview
21.9.1. Country Information
21.9.2. Market Information
21.9.3. COVID-19 Impact
21.9.4. Background Information
21.9.5. Government Initiatives
21.9.6. Regulatory Bodies
21.9.7. Regulations
21.9.8. Major Associations
21.9.9. Tax Levied
21.9.10. Corporate Tax Structure
21.9.11. Major Investments
21.9.12. Major Companies
21.10. USA Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
21.11. USA Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
21.12. USA Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
21.13. USA Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
21.14. USA Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
21.15. USA Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
22. South America Veterinary Pharmaceuticals Market
22.1. South America Veterinary Pharmaceuticals Market Overview
22.1.1. Region Information
22.1.2. Market Information
22.1.3. COVID-19 Impact
22.1.4. Background Information
22.1.5. Government Initiatives
22.1.6. Regulations
22.1.7. Regulatory Bodies
22.1.8. Major Associations
22.1.9. Tax Levied
22.1.10. Corporate Tax Structure
22.1.11. Major Investments
22.1.12. Major Companies
22.2. South America Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
22.3. South America Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
22.4. South America Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
22.5. South America Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
22.6. South America Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
22.7. South America Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
22.8. Brazil Veterinary Pharmaceuticals Market
22.9. Brazil Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
22.10. Brazil Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
22.11. Brazil Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
22.12. Brazil Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
22.13. Brazil Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
22.14. Brazil Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
23. Middle East Veterinary Pharmaceuticals Market
23.1. Middle East Veterinary Pharmaceuticals Market Overview
23.1.1. Region Information
23.1.2. Market Information
23.1.3. COVID-19 Impact
23.1.4. Background Information
23.1.5. Government Initiatives
23.1.6. Regulatory Bodies
23.1.7. Regulations
23.1.8. Taxes Levied
23.1.9. Corporate Tax Structure
23.1.10. Associations
23.1.11. Investments
23.1.12. Major Companies
23.2. Middle East Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
23.3. Middle East Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
23.4. Middle East Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
23.5. Middle East Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
23.6. Middle East Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
23.7. Middle East Veterinary Antibiotics Market, Segmentation By Type Of Antibiotic, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
24. Africa Veterinary Pharmaceuticals Market
24.1. Africa Veterinary Pharmaceuticals Market Overview
24.1.1. Region Information
24.1.2. Market Information
24.1.3. COVID-19 Impact
24.1.4. Background Information
24.1.5. Regulatory Bodies
24.1.6. Government Initiatives
24.1.7. Regulations
24.1.8. Corporate Tax Structure
24.1.9. Associations
24.1.10. Taxes Levied
24.1.11. Investments
24.1.12. Major Companies
24.2. Africa Veterinary Pharmaceuticals Market, Historic Market Growth, 2015 – 2020, Value ($ Million)
24.3. Africa Veterinary Pharmaceuticals Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)
24.4. Africa Veterinary Pharmaceuticals Market, Segmentation By Type Of Pharmaceuticals, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
24.5. Africa Veterinary Pharmaceuticals Market, Segmentation By Animal Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)
24.6. Africa Veterinary Pharmaceuticals Market, Segmentation By End Use Channel, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook